GlassScriptPhysician profile
David H Madoff
NPI 1811965478
$669.64
in general payments reported to CMS, 2019-2025
8 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $102 · 2023: $127 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $168.24 | 2019-2020 | |
| Mediview Xr, INC. | $137.00 | 2025 | |
| Siemens Medical Solutions USA, INC. | $126.87 | 2023 | |
| Amarin Pharma, INC. | $108.99 | 2019 | |
| Boston Scientific Corporation | $79.49 | 2020 | |
| Amgen INC. | $24.90 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.45 | 2019 | |
| Medtronic Minimed, INC. | $11.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Madoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.